← All drugs Report issue

alv-100

Peptideexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Glucagon-like peptide 1 receptorAGONIST
GLP1R agonist
- Glucagon-like peptide 1 receptor (GLP1R) ↗
Gastric inhibitory polypeptide receptorANTAGONIST
GIPR antagonist
- Gastric inhibitory polypeptide receptor (GIPR) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No